Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

10.40
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
9.30
Today|||52-Week Range
17.55
-23.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues73.0M56.3M59.9M61.3M
 
 
 
 
 
Cost of Goods Sold8.9M9.5M9.6M10.0M
 
 
 
 
 
Depreciation And Amortization7.8M7.4M7.5M7.5M
 
 
 
 
 
 
Operating ExpensesGross Income56.3M39.4M42.9M43.8M
 
 
 
 
 
General Expenses22.8M28.2M31.9M22.6M
 
 
 
 
 
Research And Development11.0M10.3M19.1M10.1M
 
 
 
 
 
Total Operating Expenses39.5M45.1M48.9M40.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income33.5M11.2M11.0M21.2M
 
 
 
 
 
Extraordinary Charge-14.0M-365.0K-186.8M0.00
 
 
 
 
Interest Expense On Debt5.6M2.9M2.9M3.0M
 
 
 
 
 
Other Expenses-7.0M211.0K-476.0K-683.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income6.9M8.2M-179.2M17.6M
 
 
 
 
 
Income Taxes-8.4M-3.6M-1.9M-7.2M
 
 
 
 
 
Net Income15.3M4.6M-181.2M10.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS43.0M43.4M46.2M46.3M
 
 
 
 
 
Shares To Calculate EPS Diluted44.9M62.1M46.2M65.1M
 
 
 
 
 
 
Earnings Per ShareEPS$0.34$0.10-$3.92$0.19
 
 
 
 
 
EPS Diluted$0.34$0.10-$3.92$0.19